Answers are grounded in this paper and cite their sources.
Isolation of three new compounds shows strong α-glucosidase inhibition in Curcuma aromatica, suggesting potential for diabetes treatment.
Three new phenolic compounds, curaromin A–C (1–3), were isolated from the rhizomes of Curcuma aromatica Salisb. through chromatographic technique. All chemical structures were determined from HRESIMS and 1D-, 2D-NMR data. The absolute configuration of curaromin C (3) was established by ECD spectra. All isolated compounds were evaluated for inhibitory activity against α-glucosidase and urease. Compounds 1–3 exhibited strong α-glucosidase inhibition, with curaromin A (1) being the most potent (IC50 = 9.8 µM), followed by curaromin B (2; IC50 = 26.4 µM) and curaromin C (3; IC50 = 42.0 µM), and all were more active than acarbose (IC50 = 168.0 µM). In contrast, these compounds showed weak to negligible urease inhibition with IC50 values of 249.2 µM (compound 1) and 247.7 µM (compound 2), compared with hydroxyurea (IC50 = 77.45 µM). These results identify curaromins as promising lead scaffolds for the development of potent α-glucosidase inhibitors.
No takes yet. Share an insight, caveat, or question.
Hoang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: